Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0001193125-26-267587

Options or other derivatives

  • Director acquired 94,313 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
DEPTULA-HICKS DARLENE M Director 2026-06-09 Grant or award · Stock Option (Right to Buy) +84,557 84,557 D
DEPTULA-HICKS DARLENE M Director 2026-06-09 Grant or award · Stock Option (Right to Buy) +9,756 9,756 D
Loading xslF345X06/ownership.xml…